Jove
Visualize
联系我们

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Beneficial effect of lactate in neurodegenerative diseases: Association with downregulation of C-X-C motif chemokine receptor 4 signaling.

Neural regeneration research·2026
Same author

Amyloid-β is NOT only the most promising target for Alzheimer's disease.

Neural regeneration research·2024
Same author

Bone marrow-derived microglia confer neuroprotection to a mouse model of amyotrophic lateral sclerosis.

Neural regeneration research·2024
Same author

Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer's disease treatment.

Neural regeneration research·2021
Same author

Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.

The Journal of biological chemistry·2020
Same author

Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.

Journal of Alzheimer's disease : JAD·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Beka Solomon1

  • 1Tel Aviv university, Tel Aviv, Israel.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

针对粉样前体蛋白 (APP) 处理的新抗体在阿尔茨海默病模型中显著减少了tau病理. 这种方法通过降低酸化和相关的激酶活性,为治疗病症提供了一种新的策略.

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 免疫学 免疫学 免疫学

背景情况:

  • 阿尔茨海默氏症 (AD) 和陶病症涉及陶过酸化和神经纤维状的形成,导致神经退行.
  • 目前的治疗方法是通过激酶调制或免疫治疗病理性酸的酸化.
  • 粉样蛋白前体蛋白 (APP) 通过BACE1的裂变有助于超出Aβ生产的AD病理,像β-AICD和sAPPβ这样的片段共享神经毒性.

研究的目的:

  • 引入和评估一种创新的治疗策略,以降低酸化陶水平.
  • 在AD小鼠模型中研究针对APP (BBS1) 的β-分泌酶裂解部位的抗体的疗效.
  • 评估BBS1对认知功能,粉样蛋白病理和陶酸化的影响.

主要方法:

  • 开发特定部位单克隆抗体 (BBS1) 来阻止内细胞APP处理的启动.
  • 在三重转基因AD小鼠中,通过迷你奥斯摩斯给BBS1进行脑内脑室内给药,持续一个月.
  • 通过生物化学和组织学分析评估认知功能,粉样蛋白和病理 (总,酸化,PHF1,GSK3β水平).

主要成果:

  • 在AD小鼠中,BBS1的使用改善了认知功能.
  • 观察到显著的减少:51%的总tau,80%的化tau (AT-8),和56%的配对螺旋丝 (PHF1).

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451
  • 还记录了GSK3β的显著下降74%,这是一个关键的陶化激酶.
  • 结论:

    • GSK-3β,APP和tau之间的相互作用有助于神经元细胞毒性,可能涉及核转录事件.
    • 通过β-分泌酶抑制准APP处理为tau相关的神经退行提供了一个有前途的治疗途径.
    • 了解这些复杂的途径对于开发有效的病疗法至关重要.